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AbstrACt
Purpose Adults and children with intellectual disability 
(ID) are vulnerable to preventable morbidity and mortality 
due to poor quality healthcare. While poor quality care 
has been commonly identified among children with ID, 
evidence of the patient safety outcomes for this group is 
lacking and therefore explored in this review.
Data sources Systematic searches of six electronic 
bibliographic research databases were undertaken 
from January 2000 to October 2017, in addition to hand 
searching.
study selection Keywords, subject headings and MeSH 
terms relating to the experience of iatrogenic harm during 
hospitalisation for children with ID were used. Potentially 
relevant articles were screened against the eligibility 
criteria. Non-English language papers were excluded.
Data extraction Data regarding: author(s), publication 
year, country, sample, health service setting, study design, 
primary focus and main findings related to measures of 
quality and safety performance were extracted.
results of data synthesis Sixteen studies met 
the inclusion criteria, with three themes emerging: the 
impact of the assumptions of healthcare workers (HCWs) 
about the child with ID on care quality and associated 
safety outcomes; reliance on parental presence during 
hospitalisation as a protective factor; and the need for 
HCWs to possess comprehensive understanding of the 
IDs experienced by children in their care, to scientifically 
deduce how hospitalisation may compromise their safety, 
care quality and treatment outcomes.
Conclusion When HCWs understand and are 
responsive to children’s individual needs and their ID, 
they are better placed to adjust care delivery processes 
to improve care quality and safety during hospitalisation 
for children with ID.
IntroDuCtIon
The provision of a safe, effective and high-
quality healthcare is an unalienable human 
right.1 Poor quality care during hospital-
isation is associated with iatrogenic harm 
and adverse events (AEs)2 3 making it a key 
global concern.4 The estimated rate of AEs in 
Organisation for Economic Co-operation and 
Development countries is 10% of hospitalised 
adults, which is thought to be conservative.2 5 
In the paediatric context, reported rates of 
AEs for children during hospitalisation vary 
internationally from 9.2% in Canada,6 14.2% 
in the UK7 and 36.7% in the USA.8 Chil-
dren are vulnerable to AEs due to unique 
iatrogenic risks; for example, in children, 
drug dosage calculations are weight-based, 
commonly resulting in medication errors.3 
Greater vulnerability to poor quality care 
during hospitalisation is evident in partic-
ular populations.4 People with intellectual 
disability (ID) have higher rates of prevent-
able, premature mortality than the general 
population9 10 and experience poorer quality 
What is already known on this topic?
 ► Approximately 1% to 3% of all children globally 
have intellectual disability (ID).
 ► Adverse events during hospitalisation are common, 
occurring in approximately 9.2% to 36.7% of 
children.
 ► People with ID are admitted to hospital more 
frequently than their peers, but rates and 
antecedent factors of adverse events among this 
population are unknown.
What this study hopes to add?
 ► To minimise adverse events among children with ID, 
and promote greater equity in care, it is necessary 
to understand the specific risks associated with 
care for this population.
 ► The synthesised literature presented shows that 
when healthcare workers understand the child 
with ID and how hospitalisation can increase their 
vulnerability to iatrogenic harm, disparate treatment 
outcomes can be avoided.
 ► Healthcare workers can improve care quality and 
optimise treatment outcomes for these children 
during hospitalisation by engaging with parents/
carers when planning care.
2 Mimmo L, et al. BMJ Paediatrics Open 2018;2:e000201. doi:10.1136/bmjpo-2017-000201
Open Access
care during hospitalisation.11 12 This represents a clear 
health inequity for people with ID,9 13 exacerbated by 
the challenges in identifying and reporting patient safety 
issues among this population,12 which make it difficult to 
quantify their incidence of AE.
Children with complex medical needs are reported to 
experience higher rates of AEs and prolonged admissions 
during hospitalisation.6 14 For children with ID, the possi-
bility of experiencing iatrogenic harm is compounded 
by the unique vulnerabilities of children to AEs during 
hospitalisation,3 14 and the poor care quality experienced 
by patients with ID.9 11 It is imperative to determine and 
address the features of hospitalisation that increase the 
likelihood of children with ID experiencing poor quality 
care, which manifest as iatrogenic harm and AEs. The 
vulnerability of children with ID to experience poor 
quality and less safe care is an ethically and economi-
cally significant issue, yet one that is underexamined.
This study aimed to provide a narrative synthesis of 
published evidence concerning the experience of iatro-
genic harm during hospitalisation for children with ID 
to discern the evidence base and knowledge gaps. The 
review findings highlight opportunities for policy changes 
and quality improvement (QI) interventions that could 
enhance the quality of care delivered to children with ID 
internationally.
MethoDs
The Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses statement is an evidence-based approach 
for reporting in systematic reviews and meta-analyses that 
was used to guide the reporting of this review.15
eligibility criteria
Inclusion criteria
Since the 1999 publication of the pivotal work, To Err is 
Human, patient safety research has intensified in magni-
tude and scope.2 As such, we searched for publications in 
English published since 2000 that met the criteria listed 
below.
Participants
Children (<18 years of age) in hospital as inpatients, 
aligning with the United Nations definition of child.16 
Included publications were required to reference chil-
dren with ID. This could include either a specific condi-
tion known to include ID, such as Down syndrome (DS), 
or terms that are synonymous with ID such as cognitive 
impairment, learning disability or developmental disa-
bility.13
Intervention
AEs, which could be described using any of the following 
terms: adverse event, medical error, near miss, adverse 
incident, unsafe care, patient safety incident or problems 
with quality of care.
Comparator
Clinical outcomes for children without ID of a care 
process known to require hospitalisation.
Outcomes
Either clinical outcomes for children with ID of a proce-
dure known to require hospitalisation, self- or family/
carer-reported outcomes of such care experiences, or any 
other terms referring to objective or subjective measures 
of the quality and safety (Q&S) of inpatient healthcare.
Exclusion criteria
Publications were excluded if they were published prior 
to 2000, were not available in English, did not focus on 
patient safety or quality in children who were inpatients 
and under 18 years or did not include reference to chil-
dren with ID in the abstract. Publications of the following 
issues were excluded:
 ► primary care settings
 ► inpatient mental health settings
 ► risks of hospitalisation due to pre-admission patient 
factors
 ► hospital admissions of <24 hours
 ► effectiveness of surgery without a non-ID comparator
 ► errors in diagnosis of ID or medical negligence
 ► patient/parent satisfaction with healthcare services 
which did not focus on adverse safety events
 ► case reviews
 ► or rates of hospitalisation and/or healthcare utilisa-
tion by children with ID.
Publications that did not include analysis of impacts on 
care quality and patient safety were excluded. The final 
exclusion criteria ensured that included publications 
focused on inpatient care, as short stay contexts present 
other Q&S concerns that warrant separate research.2
study identification
A range of text words, synonyms and subject headings 
for the major foci of this study were used to undertake a 
systematic search of six electronic databases from January 
2000 to October 2017. An initial search was conducted 
in Medline to refine the search terms (see online 
supplementary appendix 1 for search terms). The 
remaining searches were conducted from 3 November 
to 11 November 2017, involving MEDLINE, EMBASE, 
CINAHL, PsychInfo, Scopus and Web of Science. Hand 
searching of reference lists of included publications was 
also undertaken to ensure that all relevant sources were 
included for data extraction and synthesis.
study selection and data extraction
Titles and abstracts were screened, and a copy of the full 
paper was obtained for relevant articles. The following 
data were extracted from eligible publications: author(s), 
publication year, country, sample, health service setting, 
study design and main focus. Where available, data 
extraction included main findings related to measures of 
Q&S performance, such as length of stay, and morbidity 
and mortality outcomes, as well as any self-reported 
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experiences of AEs or iatrogenic harm, unsafe care or 
concerns with quality of care.
Assessment of the quality of the studies
The quality of included publications was assessed by the 
authors using the Quality Assessment Tool for Studies 
with Diverse Designs.17 Using this tool, the authors 
assessed the study quality of the included publications 
using a four-point scale (0–3) against 16 criteria to indi-
cate the quality of each publication and the overall body 
of evidence. One reviewer (LM) individually assessed 
all publications and a second reviewer independently 
assessed a subset of the publications; disagreements 
were resolved through discussion resulting in substan-
tial agreement (κ=0.75) between reviewers on a random 
sample of 25% of the papers. Because there were few 
publications, we did not exclude publications based on 
the quality assessment. Quality assessment data was used 
to explore the strength of the available evidence.
narrative synthesis of key themes of included publications
The findings of included publications were analysed 
using a narrative synthesis approach, based on the study 
objectives, to elicit key themes articulated in the litera-
ture.18 A narrative approach was necessary to synthesise 
the heterogeneous qualitative and quantitative findings.19 
Overarching descriptions of each publication were tabu-
lated (see online supplementary table S1), then patterns 
in the data were explored to identify consistent themes 
across the publications. Regular discussions among the 
study team helped refine the analysis and enhance study 
validity.
results
Title and abstract screening resulted in the identification 
of 30 publications that fulfilled the inclusion criteria. 
From these, 11 publications were eligible based on the 
full text review, with a further five identified from refer-
ence list searches. A total of 16 publications were included 
in the review (see figure 1).
Characteristics of included studies
A list of included studies, with titles, aims, method-
ology, participants and main findings with key themes, 
is displayed in online supplementary table S1. Eleven 
publications were published since 2010. All were set in 
specialist paediatric units, and all but one in high-income 
countries. Seven publications were from the USA, five 
from the UK, two from The Netherlands, and one each 
from Canada, India and Japan.
Twelve publications used quantitative methodologies, 
though no publication specified rates of iatrogenic harm 
or AEs among children with ID. In eight publications, 
data were extracted from a single centre, three publi-
cations used data from a national database and one was 
a multicentre study. Four publications used qualitative 
Figure 1 Study selection flowchart.
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methods to explore the experience of hospitalisation for 
children with ID within a specific health service, without 
comparator populations.
While the study population of interest was all children 
with ID, 10 publications were specific to children with 
DS, with the remaining six inclusive of any ID condi-
tion. The postoperative experience for children with 
DS compared with children without DS was described in 
10 studies. Of these, six studies related to specifically to 
cardiac surgery outcomes,20–25 and two considered anaes-
thetics and/or pain management after surgery.26 27 The 
remaining two studies looked at surgical intervention for 
Hirschsprung’s disease, comparing outcomes in children 
with and without DS.28 29
Two papers reviewed the comparative hospital experi-
ence for children with non-specific ID to children without 
ID. One of these described the post general anaesthetic 
experience for children with complex special healthcare 
needs, referencing developmental disorders and DS in 
the abstract as a factor of interest.26 The final paper inves-
tigated the assessment and management of pain in chil-
dren with and without ID after spinal surgery.30
study quality
Diverse quality was seen across publications when 
assessed against the quality criteria17 (see supplementary 
table S2). Most provided theoretical background to the 
study, and descriptions of the methods for data collection 
and analysis. All but one publication relied on opportun-
istic sampling through a single centre, or retrospective 
data from existing databases. Subsequently, sample sizes 
were wide ranging, though study populations were gener-
ally well described. Discussion of limitations varied; most 
gave concise critiques, though two publications lacked 
any critique of limitations.
Key themes
Three main themes were identified: the impact of HCWs 
assumptions about the child with ID on care quality and 
associated safety outcomes; reliance on parental pres-
ence during hospitalisation as a protective factor from 
poor care quality and safety outcomes; and the need for 
HCWs to understand the child and the ID to know how 
hospitalisation may compromise their safety, care quality 
and treatment outcomes. Each theme is described below.
The impact of HCWs assumptions about the child with ID on care 
quality and associated safety outcomes
Labels, assumptions and stereotyping were described 
in three publications, which had positive and negative 
impacts on care provision.31–33 Having a diagnosis or 
label of an ID can be beneficial for parents to negotiate 
their child’s care needs with HCWs32 and for early diag-
nosis to maximise treatment outcomes of comorbidi-
ties.21 Assumptions, however, made by HCWs regarding 
the child’s behaviour, cognitive ability or experience of 
pain may mean they do not understand the unique needs 
of each child.31–34 Generalisations regarding analgesic 
requirements or behaviour led to experiences of poor 
quality care and adverse outcomes during hospitalisation 
for the child with ID.26 32
The influence of subtle assumptions and stereotyping 
of children with ID is highlighted in pain assessment.29 
Children with ID had lower pain scores and reduced 
administration of analgesia than children without 
ID,26 27 30 34 and two publications suggest that this may 
be due to HCW’s preconceptions.26 34 Several authors 
commented their findings challenged long-held beliefs 
regarding the benefit of surgical interventions to treat 
comorbidities in children with DS,23–25 28 or effective 
assessment and management of pain in children with 
ID.27 30 34
Several publications found that parents identified ready 
access to healthcare, effective communication between 
patients and HCWs, and positive treatment outcomes, 
as being dependent on the assumptions, stereotypes and 
judgements of HCWs.31–33
Parents/carers consistently reported that assump-
tions, stereotypes and judgements about their child 
led to poor care experiences and safety concerns,31 32 
compounded by a lack of effective communication.32 33 
Four publications found, to some extent, that parents/
carers felt HCW judgements about them or their child 
with ID influenced the quality of care their child 
received.31–33 35
Reliance on parental presence during hospitalisation as a 
protective factor from poor care quality
HCWs reliance on parental presence to supervise, protect 
and advocate for the care of their child was described in 
four publications31–33 35, and to assist in the assessment of 
pain in two publications.26 30 HCWs reliance on parents 
also manifest as an expectation for parents/carers to 
manage their child’s medical needs and behaviour 
during hospitalisation.33 35 Parents felt this reliance was 
frustrating when negotiating their child’s care needs with 
HCWs.31 32 Aston et al32 identified this tension; HCWs 
relied on parental presence during hospitalisation only 
to judge the parent when they provide a lot of detail.32 
As one parent said, 'I found as soon as I started to talk 
and say what James’ meds were, what his seizure activity 
was, that he was non-verbal, I didn’t stop […] and it 
was just like all of a sudden ‘well she’s a know-it-all’ and 
that’s not my intent, my intent was so that people knew 
James’ (p301).32
To overcome this reliance, parents/carers felt it was 
important that HCWs listened to them and viewed them 
as the expert of their child.31 33 35 In knowing more about 
the child and their ID label by listening to parents, several 
publications found that HCWs can adapt the hospital 
environment, such as bed location, and negotiate the 
child’s care needs, to minimise poor care experiences 
during hospitalisation.31–33 When HCWs understood the 
complexities of their child’s medical needs in the context 
of the current hospitalisation31 33 35 reliance on parental 
presence could be lessened.
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Need for HCWs to understand the child and the ID to know how 
hospitalisation may compromise their safety, care quality and 
treatment outcomes
Having specific knowledge about a child’s ID can mean 
HCWs identify responses or physiological susceptibili-
ties to the hospital environment that impact on treat-
ment outcomes,20 29 30 34 and may have a protective value 
against poor morbidity and mortality related to treat-
ment.21 23 30 When HCWs apply knowledge of the child 
with ID and make adjustments to care delivery and the 
hospital environment during hospitalisation, it may 
reduce poor quality care and clinical complications.33 
For example, understanding of how known immunity 
issues in DS contributes to postoperative infections was 
identified in four publications,21 22 28 29 though mitigation 
strategies were not reported. One publication noted that 
this susceptibility may have contributed to additional 
intensive care support in children with DS.21 Another 
publication suggested that knowledge of DS could be 
protective, finding children with DS ‘are predisposed to 
complications and thus warrant more cautious manage-
ment’ (p181).28
Parents generally perceived ID labels as important for 
HCWs to know, as the hospital and HCWs then knew 
something about the needs of their child to ensure 
quality care.32 33 Two publications reported that HCWs 
must understand the child with ID and their needs during 
care planning to optimise the care quality during hospi-
talisation.31 33 Aston et al22 commented that reducing the 
vulnerability of children with ID to poor quality care goes 
beyond educating HCWs, necessitating broader social 
and hospital system change.32
DIsCussIon
The aim of this research was to synthesise published 
evidence regarding the experience of iatrogenic harm 
during hospitalisation for children with ID. Sixteen 
publications, comprising seven from the US, five from 
the UK, two from The Netherlands, and one each from 
Canada, India and Japan, met the inclusion criteria. 
There is evidence that HCWs stereotype behaviours31–33 
and overlook factors associated with ID that predispose 
the child to poor quality care and harm.22 32
Behaviours of the child with ID during hospitalisa-
tion may be interpreted or stereotyped as normal, when 
they are in fact an expression of pain or discomfort.26 30 
Assumptions around the experience of pain or behaviour 
may result in unnecessary respiratory compromise, admis-
sion to intensive care and prolonged hospital admission 
for the child with ID.29 34 This demonstrates that there are 
specific aspects of hospitalisation that expose children 
with ID to harms that are preventable, avoidable and not 
experienced to the same extent by children without ID.
Implications
An awareness of the child and their ID, or having a label 
of ID, was seen to be beneficial,32 33 and may even be 
protective against poor outcomes.21 23 28 30 Several publi-
cations noted that children with DS are understood to 
have compromised immunity,21 22 28 29 which can increase 
their susceptibility to healthcare-associated infections, 
compared with children without DS. This is assumed 
to be the reason children with DS are shown to have 
more non-cardiac complications postoperatively, such 
as respiratory illness and surgical site infections.21 22 28 
Exploration into care quality factors of hospitalisation 
that increase infection risk for children with DS would 
add to the knowledge base for this population.
Inadequate or insufficient measures of pain and pain 
management were also identified, resulting in respira-
tory complications or prolonged hospital admission.30 34 
While pain management was identified as a particular 
challenge for this group, only four publications explored 
this, suggesting evidence to understand the impact of 
inadequate pain management on treatment outcomes in 
children with ID is warranted.
Broad assumptions on the utility of safe and equitable 
care for children with ID were also found.23 24 26 28 This 
suggests that HCWs infrequently recognise that children 
with ID have unique care needs during hospitalisation to 
ensure safe quality of care.31 33 There is evidence of reli-
ance on parental presence to care, advocate and speak 
for their child31–33 35, and parents were often relied on 
to assess their child’s pain.26 30 This reliance infers that 
parents and hospital staff share anxieties about the child 
with ID being left alone, unprotected, in the hospital 
environment.31 Exploration into how beliefs and values 
held by HCW and parents around healthcare Q&S for 
children with ID influence the experience of care quality 
is another area of potential future study.
The paucity of research into the hospital experience 
of iatrogenic harms poses a challenge to reducing health 
inequities for children with ID. Many papers excluded 
from this review reported on the frequency of hospi-
talisations, healthcare utilisation, length of stay and/or 
complexity of healthcare needs for the child with ID,36–43 
but did not report on the influence of healthcare Q&S 
on these factors. The experience of iatrogenic harms 
for children with ID in different contexts, such as hospi-
talisation for Mental Health treatment, primary care 
and/or outpatient treatment, and day only treatment, is 
particularly lacking. Furthermore, how the experience 
of hospitalisation may vary according to severity of ID 
is not explored in any of the included papers and is an 
emerging area of interest.44
While individual teams and disciplines have devised 
various interventions to mitigate the believed perils of 
hospitalisation, QI interventions and policy changes 
that are not evidence-informed may ultimately fail to 
improve, or even possibly worsen, the problems they are 
designed to address.45 Without a clear picture and scale 
of the problem, policy-makers and healthcare leaders are 
ill equipped to mandate change.
Globally, partnerships with consumers to optimise 
healthcare Q&S, improve patient outcomes and reduce 
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healthcare costs are increasing,2 4 which is strength-
ened by international recommendations for HCW 
training in patient engagement.46 The study findings 
complement this shift, indicating that training HCWs 
to partner with families of children with ID in planning 
and implementing their healthcare can have a positive 
impact on the care quality experience.33 This could be 
integrated into formal clinical training programme for 
health professionals, and into standard healthcare organ-
isational training, guidelines and policies. Healthcare 
organisations can also support Q&S research and inter-
ventions that apply principles of experience-based co-de-
sign to facilitate HCW partnerships with consumers.47
limitations
While the study population of interest was all children 
with ID, 9 of the 12 publications were specific to children 
with DS. While findings were consistent across the DS and 
non-DS publications, the emphasis on DS may reduce the 
generalisability of the findings for all ID conditions. The 
search strategy may have omitted some relevant publica-
tions, particularly due to variations in the definition of 
ID. For example, publications that referred to children 
with complex medical conditions but not explicitly ID 
were excluded from this review. Future reviews in this 
area could consider search strategies that specify terms 
for common conditions or syndromes.
A limitation of this review is the exclusion of non-En-
glish language studies. However, studies from six coun-
tries were included, traversing North America, the UK, 
Asia and Continental Europe. The identification of 
consistent themes across studies from these regions indi-
cates that the findings are likely to be generalisable to the 
experiences of children with ID in hospital across a broad 
range of contexts.
ConClusIon
The published literature indicates that the vulnerability 
of children with ID increases their likelihood of expe-
riencing poor quality care and iatrogenic harm during 
hospitalisation, impacting treatment outcomes. By 
listening to parents to learn about the child and their ID, 
HCWs and organisations can tailor healthcare delivery 
and the hospital environment to reduce or mitigate iatro-
genic harm and AEs, optimising treatment outcomes. 
Ensuring HCWs are knowledgeable about the children 
they care for and their ID is critical to achieving greater 
equity for this group. Partnering with families of chil-
dren with ID in planning and implementing their care 
needs during hospitalisation is therefore important. 
Embedding patient engagement principles across clin-
ical training programmes, healthcare policy and practice 
may enable and upskill HCWs to ensure a positive care 
quality experience for all children during hospitalisation.
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